← Leaderboards
Sean Avedissian
University Of Nebraska Medical Center
$862,196
Attributed
$862,196
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $173.2K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$862,196 · 1
By mechanism
K23$862,196 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- James B Turpen$19,347,748
- Anuja Ghorpade$11,383,660
- Anna Dunaevsky$17,913,425
- Huangui Hank Xiong$8,343,527
- William F Elmquist$6,030,767
Others in their field
Other Emerging Leaders on “Clinical Pharmacology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,494,514
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,260,629
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Susan M Landau · University Of California Berkeley$47,252,026
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
Research focus
Clinical PharmacologyClinical ResearchClinically SignificantAbsorptionCharacteristicsAnimal ModelCerebrospinal FluidAnti-Retroviral AgentsAntiretroviral TherapyAids DementiaAgreementAnatomyBasic ScienceBloodAnimalsAids Clinical Trial GroupBrainBrain Endothelial CellCareerCareer DevelopmentCcl2 GeneCell ModelAwardCohort
Grant awards (5)
Investigations of antiretroviral therapy penetration in cerebrospinal fluid$173,151
K23 · FY2025 · MH · contact PI
Investigations of antiretroviral therapy penetration in cerebrospinal fluid$172,463
K23 · FY2024 · MH · contact PI
Investigations of antiretroviral therapy penetration in cerebrospinal fluid$173,134
K23 · FY2023 · MH · contact PI
Investigations of antiretroviral therapy penetration in cerebrospinal fluid$173,001
K23 · FY2022 · MH · contact PI
Investigations of antiretroviral therapy penetration in cerebrospinal fluid$170,447
K23 · FY2021 · MH · contact PI